Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study

References

• Swerdlow SC, Harris NL, Jaffe ES, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 24th ed.; 2017.
   Google Scholar
• Toft N, Birgens H, Abrahamsson J, et al. Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia. Leukemia. 2018;32(3):606–615.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–2101.
   PubMed Web of Science ®Google Scholar
• Othus M, Kantarjian H, Petersdorf S, et al. Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson. Leukemia. 2014;28(2):289–292.
   PubMed Web of Science ®Google Scholar
• Halpern AB, Culakova E, Walter RB, et al. Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit. JAMA Oncol. 2017;3(3):374–381.
   PubMed Web of Science ®Google Scholar
• Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 2011;96(2):231–237.
   PubMed Web of Science ®Google Scholar
• Keenan T, LeBlanc TW, Traeger L, et al. Outcomes for older patients with acute myeloid leukemia admitted to the intensive care unit. Blood. 2015;126(23):2104–2104.
   Google Scholar
• Azoulay E, Mokart D, Pene F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium–a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique study. J Clin Oncol. 2013;31(22):2810–2818.
   PubMed Web of Science ®Google Scholar
• Ostgard LS, Norgaard JM, Sengelov H, et al. Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia. 2015;29(3):548–555.
   PubMed Web of Science ®Google Scholar
• Young J, Badgery-Parker T, Dobbins T, et al. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49(2):258–264.
   PubMed Web of Science ®Google Scholar
• Jackson K, Mollee P, Morris K, et al. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leuk Lymphoma. 2014;55(1):97–104.
   PubMed Web of Science ®Google Scholar
• Pohlen M, Thoennissen NH, Braess J, et al. Patients with acute myeloid leukemia admitted to intensive care units: outcome analysis and risk prediction. PLOS One. 2016;11(8):e0160871.
   PubMed Web of Science ®Google Scholar
• Magid T, Haase N, Andersen JS, et al. Intensive care of haematological patients. Dan Med J. 2012;59(3):A4395.
   PubMed Web of Science ®Google Scholar
• Kraguljac AP, Croucher D, Christian M, et al. Outcomes and predictors of mortality for patients with acute leukemia admitted to the intensive care unit. Can Respir J. 2016;2016:3027656.
   PubMed Web of Science ®Google Scholar
• Yau E, Rohatiner AZ, Lister TA, et al. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer. 1991;64(5):938–942.
   PubMed Web of Science ®Google Scholar
• Lloyd-Thomas AR, Dhaliwal HS, Lister TA, et al. Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med. 1986;12(4):317–324.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549.
   PubMed Web of Science ®Google Scholar
• Ostgard LS, Norgaard JM, Raaschou-Jensen KK, et al. The Danish national acute leukemia registry. CLEP. 2016;8:553–560.
   Google Scholar
• Ostgard LS, Norgaard JM, Severinsen MT, et al. Data quality in the Danish national acute leukemia registry: a hematological data resource. Clin Epidemiol. 2013;5:335–344.
   PubMedGoogle Scholar
• Christiansen CF, Moller MH, Nielsen H, et al. The Danish intensive care database. Clin Epidemiol. 2016;8:525–530.
   PubMed Web of Science ®Google Scholar
• Population in Denmark 2019; 2019.
   Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92(7):2322–2333.
   PubMed Web of Science ®Google Scholar
• Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206–213.
   PubMed Web of Science ®Google Scholar
• Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
   PubMed Web of Science ®Google Scholar
• Parner ET, Andersen PK, Overgaard M. Cumulative risk regression in case-cohort studies using pseudo-observations. Lifetime Data Anal. 2020;26(4):639–658.
   PubMed Web of Science ®Google Scholar
• Andersen PK, Syriopoulou E, Parner ET. Causal inference in survival analysis using pseudo-observations. Stat Med. 2017;36(17):2669–2681.
   PubMed Web of Science ®Google Scholar
• Kjaersgaard MI, Parner ET. Instrumental variable method for time-to-event data using a pseudo-observation approach. Biometrics. 2016;72(2):463–472.
   PubMed Web of Science ®Google Scholar
• Hong WJ, Medeiros BC. Unfavorable-risk cytogenetics in acute myeloid leukemia. Expert Rev Hematol. 2011;4(2):173–184.
   PubMed Web of Science ®Google Scholar
• Wunsch H, Linde-Zwirble WT, Harrison DA, et al. Use of intensive care services during terminal hospitalizations in England and the United States. Am J Respir Crit Care Med. 2009;180(9):875–880.
   PubMed Web of Science ®Google Scholar
• Prin M, Wunsch H. International comparisons of intensive care: informing outcomes and improving standards. Curr Opin Crit Care. 2012;18(6):700–706.
   PubMed Web of Science ®Google Scholar
• Ostgard LS, Norgaard JM, Sengelov H, et al. Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study. Leukemia. 2014;28(9):1926–1929.
   PubMed Web of Science ®Google Scholar
• Christiansen CF, Johansen MB, Langeberg WJ, et al. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011;22(4):399–406.
   PubMed Web of Science ®Google Scholar
• Contejean A, Lemiale V, Resche-Rigon M, et al. Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Reanimation Respiratoire en Onco-Hematologique (Grrr-OH) study. Ann Intensive Care. 2016;6(1):102.
   PubMedGoogle Scholar
• Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013;54(8):1724–1729.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Schellongowski P, Darmon M, et al. The intensive care medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017;43(9):1366–1382.
   PubMed Web of Science ®Google Scholar
• Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North America and Western Europe. Crit Care Med. 2008;36(10):2787–2793, e2781–e2789.
   PubMed Web of Science ®Google Scholar
• Cardoso LT, Grion CM, Matsuo T, et al. Impact of delayed admission to intensive care units on mortality of critically ill patients: a cohort study. Crit Care. 2011;15(1):R28.
   PubMed Web of Science ®Google Scholar
• Pene F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24(4):643–649.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Pene F, Darmon M, et al. Managing critically ill hematology patients: time to think differently. Blood Rev. 2015;29(6):359–367.
   PubMed Web of Science ®Google Scholar